Home

Prestige Consumer Healthcare Inc. Common Stock (PBH)

63.20
+0.23 (0.37%)
NYSE · Last Trade: Sep 16th, 10:41 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close62.97
Open62.82
Bid62.89
Ask63.57
Day's Range62.76 - 63.29
52 Week Range61.93 - 90.04
Volume634,458
Market Cap3.16B
PE Ratio (TTM)14.80
EPS (TTM)4.3
Dividend & YieldN/A (N/A)
1 Month Average Volume604,130

Chart

About Prestige Consumer Healthcare Inc. Common Stock (PBH)

Prestige Brand Holdings is a consumer goods company that specializes in marketing and distributing a diverse portfolio of over-the-counter healthcare and personal care products. The company focuses on providing solutions in various categories, including feminine hygiene, oral care, and vitamins, with a strong emphasis on brand development and consumer engagement. By utilizing a combination of established and emerging brands, Prestige Brand Holdings aims to meet the evolving needs of consumers while driving growth and profitability within the competitive health and wellness market. Read More

News & Press Releases

Sidoti Events, LLC's Virtual September Small-Cap Conference
NEW YORK, NY / ACCESS Newswire / September 16, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day September Small-Cap Conference taking place Wednesday and Thursday, September 17-18, 2025. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Via ACCESS Newswire · September 16, 2025
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 4, 2025 at 12:45 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the “Investors” section and the “Events and Presentations” tab, or by using the following link:
By Prestige Consumer Healthcare Inc. · Via GlobeNewswire · September 4, 2025
Looking Into Prestige Consumer's Recent Short Interestbenzinga.com
Via Benzinga · August 8, 2025
Prestige (PBH) Q1 Revenue Falls 6.6%fool.com
Via The Motley Fool · August 7, 2025
Earnings Scheduled For August 7, 2025benzinga.com
Via Benzinga · August 7, 2025
Earnings Scheduled For August 6, 2025benzinga.com
Via Benzinga · August 6, 2025
How Is The Market Feeling About Prestige Consumer?benzinga.com
Via Benzinga · June 3, 2025
Earnings Scheduled For May 8, 2025benzinga.com
Via Benzinga · May 8, 2025
Earnings Scheduled For February 6, 2025benzinga.com
Via Benzinga · February 6, 2025
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results
TARRYTOWN, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter fiscal 2026 ended June 30, 2025.
Insights Ahead: Prestige Consumer's Quarterly Earningsbenzinga.com
Via Benzinga · August 6, 2025
Insights Ahead: Prestige Consumer's Quarterly Earningsbenzinga.com
Via Benzinga · August 5, 2025
Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results
TARRYTOWN, N.Y., July 15, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 first quarter earnings release on Thursday, August 7, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
What Does the Market Think About Prestige Consumer?benzinga.com
Via Benzinga · July 4, 2025
Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination
TARRYTOWN, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- Medtech Products Inc., a Prestige Consumer Healthcare Inc. company (“Medtech” or “Company”), is voluntarily recalling five lots of Little Remedies® Honey Cough Syrup (the “Product”) due to the presence of Bacillus cereus and loss of shelf-stability. Bacillus cereus (B. cereus) can cause two types of food-borne illnesses. One type is characterized by nausea, vomiting, and stomach cramps that can start 1 to 6 hours after eating or drinking contaminated food. The second type can cause stomach cramps and diarrhea that can start 8 to 16 hours after eating or drinking contaminated food. Diarrhea may be a small volume or profuse and watery. Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death.
Here's How Much You Would Have Made Owning Prestige Consumer Stock In The Last 15 Yearsbenzinga.com
Via Benzinga · June 10, 2025
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
TARRYTOWN, N.Y., June 09, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference virtually on Wednesday, June 11, 2025 at 10:30 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · June 6, 2025
UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) --  Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025.
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) --  Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025.
Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 fourth quarter and year-end earnings release on Thursday, May 8, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
Beyond The Numbers: 4 Analysts Discuss Prestige Consumer Stockbenzinga.com
Via Benzinga · March 21, 2025
Earnings Scheduled For March 21, 2025benzinga.com
Via Benzinga · March 21, 2025
Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook
TARRYTOWN, N.Y., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended December 31, 2024.
By Prestige Consumer Healthcare Inc. · Via GlobeNewswire · February 6, 2025
Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation
TARRYTOWN, N.Y., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 third quarter earnings release on Thursday, February 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.